Cadila Pharmaceuticals Limited
FDA inspection history in Ankleshwar, India, 2014 to 2024
- 1
- Form 483
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2014: one warning letter; 2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2014One warning letter, at Ankleshwar, India.
- 2024One Form 483, at Ankleshwar, India.
Cited most
Across all Cadila Pharmaceuticals Limited observations on file
- 21 CFR 211.160General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.63Equipment design, size, and location1
The complete Cadila Pharmaceuticals Limited file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Ankleshwar, India
One Form 483 and one warning letter · 2014 to 2024 · 3 observations
Latest: Form 483, May 10, 2024 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-05-10 | 483 Form 483 | Ankleshwar, India | 3 | $99 |
| 2014-10-15 | Warning letter Warning letter | Ankleshwar, India | — | $99 |
Investigators on these documents
FEI number 3002806711 · most recent document May 10, 2024
About Cadila Pharmaceuticals Limited
How many FDA Form 483s has Cadila Pharmaceuticals Limited received?
FDA Intel has 1 Form 483 on file for Cadila Pharmaceuticals Limited; the most recent is dated May 10, 2024.
When was Cadila Pharmaceuticals Limited last inspected by FDA?
The most recent FDA inspection document on file for Cadila Pharmaceuticals Limited is a Form 483 dated May 10, 2024, for the site in Ankleshwar, India.
What did FDA cite at Cadila Pharmaceuticals Limited?
The regulations cited most in the observations on file for Cadila Pharmaceuticals Limited are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time; 21 CFR 211.63 (Equipment design, size, and location), 1 time.
Has Cadila Pharmaceuticals Limited received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Cadila Pharmaceuticals Limited; the most recent is dated Oct 15, 2014.